A retrospective study evaluating the clinical outcomes of dupilumab in treatment of atopic dermatitis in patient living with HIV
Latest Information Update: 14 Jun 2021
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis; Prurigo nodularis
- Focus Adverse reactions
- 14 Jun 2021 New trial record
- 25 Apr 2021 Results presented at the American Academy of Dermatology Virtual Meeting Experience 2021